When you reach for a drug on your pharmacy shelf or in your truck, can you rely on it to be a safe, effective and high-quality product? You can if the bottle’s label includes the statement, “Approved by FDA.” The AVMA has been working with the Food and Drug Administration to keep members informed on FDA’s animal-drug approval process to ensure that you have safe and effective drugs for your patients that are high quality and properly labeled.
As part of FDA’s outreach program about the importance of using approved products, the agency recently wrote two letters to veterinarians about three significant new drug approvals for dogs and horses. One letter came after FDA’s approval of both INCURIN (estriol) Tablets and PROIN (phenylpropanolamine hydrochloride) Chewable Tablets to control urinary incontinence in dogs. The other was after the agency approved PRASCEND (pergolide mesylate) Tablets to control the clinical signs associated with Equine Cushing’s Disease. FDA’s “Dear Veterinarian” letters provided veterinarians with drug information, explained the benefits of using FDA-approved drugs for patients and discussed the legal requirements for compounding animal drugs.
You can read the FDA’s “Dear Veterinarian” letters on the agency’s website, and you can follow the links below for more information about the importance of the animal-drug approval process and how to tell if a drug is FDA-approved.